EQ - Equillium, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqCM). Stock Information · Stock Chart · Analyst Coverage · Press Releases · Events & Presentations · Email Alerts & Contacts · SEC Filings · Corporate Governance. Track Equillium Inc (EQ) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable. Get the latest Equillium Inc (EQ) real-time quote, historical performance, charts, and other financial information to help you make more informed trading. Find the latest analyst research, reports, and ratings for Equillium, Inc. Common Stock (EQ) at smartwebs.site
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory. Equillium Inc Registered Shs's market capitalization is $ M by M shares outstanding. Equillium Stock Snapshot. Bid. Bid Size. Ask. Stock Quote: NASD: EQ · Day's Open. $ · Closing Price. $ · Intraday Low. $ · Intraday High. $ · Volume. , Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends. EQ - Equillium Inc - Stock screener for investors and traders, financial visualizations. Equillium, Inc. engages in the development of products for severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. 17 minutes ago. Equillium's market cap is calculated by multiplying EQ's current stock price of $ by EQ's total outstanding shares of 35,, Equillium, Inc. engages in the development of products for severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. The Equillium Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy. A high-level overview of Equillium, Inc. (EQ) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment.
EQ - Equillium Inc - Stock screener for investors and traders, financial visualizations. Equillium's stock is up 12% after sharing early data about its investigational lupus treatment. Shares of Equillium Inc. gained % in premarket trading. In the current month, EQ has received 8 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. EQ average Analyst price target in the past 3 months is $ shares of common stock at a public offering price of $ per share. Equillium anticipates total gross proceeds of approximately $ million, before. Discover real-time Equillium, Inc. Common Stock (EQ) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Looking to buy Equillium Inc Stock? View today's EQ stock price, trade commission-free, and discuss EQ stock updates with the investor community. Key Stats · Market CapM · Shares OutM · 10 Day Average VolumeM · Dividend- · Dividend Yield- · Beta · YTD % Change Equillium, Inc. (EQ) Reports Q4 Loss, Tops Revenue Estimates. Equillium (EQ) delivered earnings and revenue surprises of % and %, respectively, for the. If your shares are held in your name, you must contact our transfer agent, American Stock Transfer & Trust Company, LLC. If your shares are held in street.
EQ - Equillium, Inc. Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (NasdaqCM). 30 minutes ago. EQ - Equillium, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqCM). Stock analysis for Equillium Inc (EQ:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. View the latest Equillium Inc. (EQ) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Equillium, Inc. (smartwebs.site): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Equillium, Inc. | Nasdaq: EQ | Nasdaq. Equillium (Nasdaq: EQ), a clinical-stage biotech firm, announced its expected inclusion in the Russell Microcap Index effective July 1, This follows the. Equillium, Inc. is a clinical-stage biotechnology company. It is engaged in developing novel therapeutics to treat severe autoimmune and inflammatory disorders. Equillium Stock (NASDAQ: EQ) stock price, news, charts, stock research, profile. Stock Information · Stock Chart · Analyst Coverage · Press Releases · Events & Presentations · Email Alerts & Contacts · SEC Filings · Corporate Governance. Complete Equillium Inc. stock information by Barron's. View real-time EQ stock price and news, along with industry-best analysis.